Article

Gout and Sex: Different, and Not So Good

(EULAR 2014) New research finds erectile dysfunction common among gout patients, and distinctive differences between men and women in predisposing factors and treatment risks.

Gout management needs to be tailored by gender, according to new research presented last week at the annual meeting of the European League Against Rheumatism (EULAR) in Paris.

Women with gout are more likely than men to have metabolic-syndrome type comorbidities (hypertension, diabetes, and kidney disease) and contraindications to NSAIDs and colchicine, according to data from the North American CORRONA registry, while predisposing dietary factors such as beer, hard liquor, and beef and pork are more frequent among men. While initial features of the disease were similar, women more frequently reported disability from gout, reported Leslie Harrold MD of the University of Massachusetts Medical School in Worcester.

A separate report of a single-institution study revealed a significantly greater prevalence of erectile dysfunction (ED) among men with gout (76%) than among others without gout (30%) visiting Rutgers-Robert Wood Johnson Medical School in New Brunswick NJ.

ED was significantly more common among men over 65 who had gout, and among those with tophi, reported rheumatologist Nancy Schesinger MD. Also, ED was more severe among men with gout than among others.

The association was significant independent of hypertension, low density lipoprotein (LDL) levels, and obesity, and diabetes.

ED may signal underlying cardiovascular disease, the researchers observe, urging that all men with gout should be screened for ED.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.